(MedPage Today) — For pregnant women who received the bivalent prefusion F subunit-based respiratory syncytial virus (RSV) vaccine (RSVpreF; Abrysvo), safety outcomes were similar to those who were not vaccinated, according to interim results…
Source link : https://www.medpagetoday.com/infectiousdisease/rsv/119333
Author :
Publish date : 2026-01-08 16:00:00
Copyright for syndicated content belongs to the linked Source.
